Compare Calistoga Pharmaceuticals vs Marinus Pharmaceuticals
Customers evaluate the quality of Calistoga Pharmaceuticals's products using the following success metrics.
Overview
Calistoga Pharmaceuticals is 18 yrs old and is based in United States.
Calistoga Pharmaceuticals is a biopharmaceutical company developing multiple compounds selectively targeting the PI3K pathway, a pathway known to be involved in certain cancers and inflammatory diseases. In February 2011, Calistoga Pharmaceuticals was acquired by Gilead Sciences. The valuation of Calistoga Pharmaceuticals was $375 million.
Marinus Pharmaceuticals is 20 yrs old and is based in United States.
Marinus Pharmaceuticals is a pharmaceutical company with a high-level focus on the development of innovative therapeutics in the healthcare sector. The company's main offerings include the development of treatments for severe, rare forms of epilepsy and other seizure disorders. Marinus Pharmaceuticals primarily sells to the healthcare industry, specifically those dealing with epilepsy and CNS disorders. It was founded in 2004 and is based in Wayne, Pennsylvania.
Demo Video
Leadership
Neill Giese (Chief Security Officer)
Geoffrey Chaiken (Founder)
Funding
Investors
Gilead Sciences, Alta Partners
Canaan Partners, Domain Associates
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Calistoga Pharmaceuticals has not claimed their profile.
Work for Calistoga Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Calistoga Pharmaceuticals?
Claim your profile now.
Information not available because Marinus Pharmaceuticals has not claimed their profile.
Work for Marinus Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Marinus Pharmaceuticals?
Claim your profile now.